Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 J+Infect+Dis 2016 ; 213 (5): 738-45 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Global Mortality Impact of the 1957?1959 Influenza Pandemic #MMPMID26908781
Viboud C; Simonsen L; Fuentes R; Flores J; Miller MA; Chowell G
J Infect Dis 2016[Mar]; 213 (5): 738-45 PMID26908781show ga
Background.?Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by modeling historical mortality statistics.Methods.?We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality and development indicators to extrapolate the global burden of the pandemic.Results.?The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% confidence interval [CI], 1.2?2.6 cases/10 000 population) on average during 1957?1959. Excess mortality rates varied 70-fold across countries; Europe and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1?2 years in 18 countries (46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35%?77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million?1.5 million excess deaths) globally to the 1957?1959 pandemic.Conclusions.?The global mortality rate of the 1957?1959 influenza pandemic was moderate relative to that of the 1918 pandemic but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in several countries, pointing to a window of opportunity for vaccination in a future pandemic.